We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Presents Virtual Showcase of MicroScan Microbiology Solutions

By LabMedica International staff writers
Posted on 25 Apr 2022
Print article
Image: MicroScan WalkAway plus System for ID/AST testing (Photo courtesy of Beckman Coulter)
Image: MicroScan WalkAway plus System for ID/AST testing (Photo courtesy of Beckman Coulter)

Beckman Coulter (Brea, CA, USA) demonstrated how laboratories can improve patient outcomes with accurate detection of antimicrobial resistance and enhance workflow efficiency with its MicroScan microbiology solutions at ECCMID 2022.

Emerging antimicrobial resistance continues to be a critical issue in today’s healthcare environment. Resistance that was once considered unusual is now routine, and the microbiology laboratory has increasingly many ways, including rapid methods, to test for antimicrobial resistance. Beckman Coulter’s integrated symposium at ECCMID 2022 examined the central role of susceptibility testing and the determination of MICs in a variety of laboratory health care settings. Topics examined included new mechanisms of resistance, laboratory testing protocols and standardization across organizations, and the importance of MICs as well as SIR categories in defining antibiotic treatment, particularly with new antibiotics.

In addition, Beckman Coulter displayed its full suite of MicroScan microbiology solutions designed for every laboratory through its virtual showcase in 3D. Among its innovations for managing emerging microbial resistance that were presented virtually was the company’s DxM MicroScan WalkAway ID/AST System for the detection of emerging and critical antimicrobial resistance with gold-standard1 MIC accuracy. Designed with ease of use as a focal point, this bacterial identification and antimicrobial susceptibility testing (ID/AST) system provides streamlined workflows and enhanced performance compared to its predecessors. It enables laboratories to optimize patient care while reducing risks, costs and operational burden associated with detecting emerging antimicrobial resistance.

Related Links:
Beckman Coulter 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.